2009TumoriRequires access

Role of p53 up-regulated modulator of apoptosis in gemcitabine-induced apoptosis of human pancreatic cancer cell lines

Yan Ming-zong, Kejun Zhang, Tao Huang

Open publisher page 0 citations

Abstract

Objective:To investigate the effect of gemcitabine on the proliferation of human pancreatic cancer AsPC-1 cells in vitro and elucidate the mechanism.Methods:The vector of antisense oligoneucleotides of p53 up-regulated modulator of apoptosis (PUMA) pcDNA3.1-PUMMAS and empty vector pcDNA3.1 was transfected into AsPC-1 cells by lipofectAMINE 2000 mediation,respectively. The stable clone was selected by G418. pcDNA3.1-PUMAAS-transfected,pcDNA3.1-transfected,and control AsPC-1 cells were treated with serial concentrations(1,5,10,and 15 μmol/L)of gemcitabine for 72 h.The expressions of PUMA mRNA and protein were detected by RT-PCR and Western blotting.MTT assay was used to measure the inhibitory actions of gemcitabine on AsPC-1 cells.The apoptosis was detected by flow cytometry,Hoechst 33258 staining,and TUNEL staining.Results:Gemcitabine induced apoptosis of AsPC-1 cells and inhibited the proliferation in a dose-dependent manner. The apoptosis induced by gemcitabine was accompanied with the up-regulation of PUMA. In pcDNA3.1-PUMAAS-transfected cells,the up-regulation of PUMA induced by gemcitabine was significantly decreased compared with AsPC-1 control cells and pcDNA3.1 transfected cells.The apoptosis was inhibited and the proliferation was increased after transfection of pcDNA3.1-PUMAAS.Conclusion:Gemcitabine induced the apoptosis of AsPC-1 cells and inhibited the proliferation in vitro. The apoptosis-inducing effect was related to up-regulation of PUMA expression.

About this research paper

What this paper is about

Objective:To investigate the effect of gemcitabine on the proliferation of human pancreatic cancer AsPC-1 cells in vitro and elucidate the mechanism.Methods:The vector of antisense oligoneucleotides of p53 up-regulated modulator of apoptosis (PUMA) pcDNA3.1-PUMMAS and empty vector pcDNA3.1 was transfected into AsPC-1 cells by lipofectAMINE 2000 mediation,respectively. The stable clone was selected by G418. pcDNA3.1-PUMAAS-transfected,pcDNA3.1-transfected,and control AsPC-1 cells were treated with serial concentrations(1,5,10,and 15 μmol/L)of gemcitabine for 72 h.The expressions of PUMA mRNA and protein were detected by RT-PCR and Western blotting.MTT assay was used to measure the inhibitory actions of gemcitabine on AsPC-1 cells.The apoptosis was detected by flow cytometry,Hoechst 33258 staining,and TUNEL staining.Results:Gemcitabine induced apoptosis of AsPC-1 cells and inhibited the proliferation in a dose-dependent manner. The apoptosis induced by gemcitabine was accompanied with the up-regulation of PUMA. In pcDNA3.1-PUMAAS-transfected cells,the up-regulation of PUMA induced by gemcitabine was significantly decreased compared with AsPC-1 control cells and pcDNA3.1 transfected cells.The apoptosis was inhibited and the proliferation was increased after transfection of pcDNA3.1-PUMAAS.Conclusion:Gemcitabine induced the apoptosis of AsPC-1 cells and inhibited the proliferation in vitro. The apoptosis-inducing effect was related to up-regulation of PUMA expression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effect of gemcitabine on the proliferation of human pancreatic cancer AsPC-1 cells in vitro and elucidate the mechanism.Methods:The vector of antisense oligoneucleotides of p53 up-regulated modulator of apoptosis (PUMA) pcDNA3.1-PUMMAS and empty vector pcDNA3.1 was transfected into AsPC-1 cells by lipofectAMINE 2000 mediation,respectively. The stable clone was selected by G418. pcDNA3.1-PUMAAS-transfected,pcDNA3.1-transfected,and control AsPC-1 cells were treated with serial concentrations(1,5,10,and 15 μmol/L)of gemcitabine for 72 h.The expressions of PUMA mRNA and protein were detected by RT-PCR and Western blotting.MTT assay was used to measure the inhibitory actions of gemcitabine on AsPC-1 cells.The apoptosis was detected by flow cytometry,Hoechst 33258 staining,and TUNEL staining.Results:Gemcitabine induced apoptosis of AsPC-1 cells and inhibited the proliferation in a dose-dependent manner. The apoptosis induced by gemcitabine was accompanied with the up-regulation of PUMA. In pcDNA3.1-PUMAAS-transfected cells,the up-regulation of PUMA induced by gemcitabine was significantly decreased compared with AsPC-1 control cells and pcDNA3.1 transfected cells.The apoptosis was inhibited and the proliferation was increased after transfection of pcDNA3.1-PUMAAS.Conclusion:Gemcitabine induced the apoptosis of AsPC-1 cells and inhibited the proliferation in vitro. The apoptosis-inducing effect was related to up-regulation of PUMA expression.

Key concepts: Gemcitabine, Apoptosis, Transfection, Lipofectamine, Puma, Flow cytometry, MTT assay, Molecular biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Role of p53 up-regulated modulator of apoptosis in gemcitabine-induced apoptosis of human pancreatic cancer cell lines — Research Paper | ScholarLens